Skip to main content
Caplight Logo









SinoUnited Health

SinoUnited Health

Private
ShanghaiHealthcare & Life Scienceshttps://www.suh.cn/

Last Round

Series B

May 1, 2019

Total Funding Raised

$9.2M

Company Overview

SinoUnited Health is a healthcare provider that operates a network of clinics and a hospital in China, offering international-standard medical services to both local and expatriate patients.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Patient Engagement, Precision Medicine, Biotechnology, Medical Devices

Business Model

B2C

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

private healthcareconcierge medicinemultidisciplinary careCAR-T therapycellular immunotherapytelehealthvirtual clinicchronic disease managementdigital healthexecutive healthcorporate health servicesdirect billingmedical insuranceday surgeryminimally invasive surgery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SinoUnited Health Comparables

Compare SinoUnited Health with similar companies based on industry and business-model similarity.

SinoUnited Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Yosemite Clinic
91%
Shanghai East International Medical Center
89%
Guangzhou United Doctor Group Co., Ltd.
87%

SinoUnited Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMay 1, 2019
Series AJan 18, 2018

SinoUnited Health Investors

Notable investors and investment history

SinoUnited Health investors
InvestorRounds
Qiming Venture PartnersSeries B, Series A

Recent news

Latest coverage and updates

  • attends_eventAug 6, 2026

    SinoUnited Health attended event International Medical Forum on Aug 5th '26.

  • launchesJul 3, 2026

    SinoUnited Health launched satricabtagene autoleucel on Jul 3rd '26.

SinoUnited Health Filings

Explore SEC and related filing metadata, where available.

SinoUnited Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about SinoUnited Health's valuation, stock price, and market status.

Is SinoUnited Health a public or private company?

SinoUnited Health is a private company.

What is the current stock price of SinoUnited Health?

SinoUnited Health is a private company with no public stock price. No recent secondary market data is available.

How much is SinoUnited Health worth (valuation)?

Valuation information for SinoUnited Health is not publicly available.

Can I buy SinoUnited Health stock?

SinoUnited Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was SinoUnited Health's last funding round?

SinoUnited Health's most recent funding round was Series B on May 1, 2019.

Who are the main investors in SinoUnited Health?

Key investors in SinoUnited Health include Qiming Venture Partners.

Will SinoUnited Health IPO soon?

No public IPO plans have been announced for SinoUnited Health.

How can I track SinoUnited Health secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SinoUnited Health's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersShanghai
Employee Range13
Year Founded2016
Last FundingMay 1, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?